Derek M. Meisner

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Derek Meisner
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Derek M. Meisner

Form 4 holding Chief Legal Officer

X4 Pharmaceuticals, Inc

Security class
Common Stock
Shares / value
145,155
Estimated value
$130,640
Report date
17 Aug 2022
Price
$0.9000
Ownership
Direct
Form 4 holding Chief Legal Officer & Corp Sec

Acumen Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
71,048
Estimated value
Report date
06 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Derek M. Meisner

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .